OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study.
Lidia ClementeGilda CennamoDaniela MontorioFederica FossataroMaria Laura PassaroCiro CostagliolaPublished in: European journal of ophthalmology (2022)
OCTA allowed us to study retinal and choriocapillary vascular changes in patients with CSC treated with vPDT and eplerenone.